Spitfire Oil secures tenure over Salmon Gums resource area

AIM-listed mining company Spitfire Oil has secured the long-term tenure over the Salmon Gums lignite resource area in Western Australia.

AIM-listed mining company Spitfire Oil has secured the long-term tenure over the Salmon Gums lignite resource area in Western Australia.

In the company's interim statement for the six months ended December 31st, the company reported that it together with its subsidiaries recorded a loss before tax of A$182,907.

With cash balances of A$7.2m, the group said that it benefited from interest receipts of A$122,584 in the period.

Operating costs were reduced to A$305,491 with action taken during the period to further reduce costs, including a reduction in directors' fees.

On September 4th 2012 Spitfire Oil Pty was granted a five year renewable retention licence covering the Salmon Gums lignite resource area with no annual exploration expenditure commitments attaching to this licence other than the prescribed licence fees.

The group further reported that developing processing technologies, and in particular developments in pyrolysis technology, were being kept "under review" for possible application to process the Salmon Gums lignite.

In the meantime the directors continue to evaluate numerous alternative natural resources projects, the group said.

Mladen Ninkov, Chairman of Spitfire Oil, said: "Having ensured long term tenure over the Salmon Gums lignite deposits with minimal financial commitment, costs have been further reduced to ensure the financial stability of the company for the foreseeable future. The directors will continue to review all possible acquisition opportunities for the company."

MF

Recommended

Imperial Brands has an 8.3% yield – but what’s the catch?
Share tips

Imperial Brands has an 8.3% yield – but what’s the catch?

Tobacco company Imperial Brands boasts an impressive dividend yield, and the shares look cheap. But investors should beware, says Rupert Hargreaves. H…
20 May 2022
Investing in drugmakers: uncommon profits from curing rare diseases
Share tips

Investing in drugmakers: uncommon profits from curing rare diseases

Treatments for medical conditions with only a small number of sufferers can still be very attractive for pharmaceutical companies and investors becaus…
20 May 2022
Share tips of the week – 20 May
Share tips

Share tips of the week – 20 May

MoneyWeek’s comprehensive guide to the best of this week’s share tips from the rest of the UK's financial pages.
20 May 2022
Delivering profits: should you buy Royal Mail shares?
Share tips

Delivering profits: should you buy Royal Mail shares?

The volume of parcels delivered by Royal Mail soared during the pandemic, and so did its profits. But it has been coming under pressure lately. So, as…
19 May 2022

Most Popular

The ten highest dividend yields in the FTSE 100
Income investing

The ten highest dividend yields in the FTSE 100

Rupert Hargreaves looks at the FTSE 100’s top yielding stocks for income investors to consider.
18 May 2022
Aviva: a share for income investors to tuck away
Share tips

Aviva: a share for income investors to tuck away

Insurance giant Aviva is one of the highest yielding stocks in the FTSE 100 – and it’s cheap, too, making it a tempting target for income investors. R…
18 May 2022
Despite the crypto crash, bitcoin still has a bright future
Bitcoin & crypto

Despite the crypto crash, bitcoin still has a bright future

Cryptocurrencies have crashed hard, with bitcoin down by more than 50% from its peak. But, says Dominic Frisby, bitcoin still has a future – it is the…
19 May 2022